Tarbox Family Office, Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tarbox Family Office, Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%220.0%0.00%
Q3 2021$1,0000.0%220.0%0.00%
Q2 2021$1,0000.0%220.0%0.00%
Q1 2021$1,0000.0%220.0%0.00%
Q4 2020$1,0000.0%220.0%0.00%
Q3 2020$1,0000.0%220.0%0.00%
Q2 2020$1,000
-50.0%
22
-56.0%
0.00%
-100.0%
Q1 2020$2,000
+100.0%
50
+78.6%
0.00%
Q4 2019$1,0000.0%28
+21.7%
0.00%
Q2 2019$1,000
-50.0%
230.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
230.0%0.00%
Q4 2018$1,0000.0%23
+43.8%
0.00%
Q3 2018$1,0000.0%160.0%0.00%
Q2 2018$1,0000.0%160.0%0.00%
Q1 2018$1,0000.0%160.0%0.00%
Q4 2017$1,0000.0%160.0%0.00%
Q3 2017$1,0000.0%160.0%0.00%
Q2 2017$1,0000.0%160.0%0.00%
-100.0%
Q1 2017$1,0000.0%160.0%0.00%0.0%
Q4 2016$1,0000.0%160.0%0.00%0.0%
Q3 2016$1,0000.0%160.0%0.00%0.0%
Q2 2016$1,0000.0%160.0%0.00%0.0%
Q1 2016$1,000160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders